APA (7th ed.) Citation

A, A., A, A., S, M., RA, P., BL, W., LD, J., . . . AB, C. (2024). Mortality Benefit Among Primary Prevention Implantable Cardioverter-Defibrillator Recipients on Contemporary Heart Failure Treatment. JACC. Clinical electrophysiology, 10(5), 916. https://doi.org/10.1016/j.jacep.2024.102334

Chicago Style (17th ed.) Citation

A, Ahmed, et al. "Mortality Benefit Among Primary Prevention Implantable Cardioverter-Defibrillator Recipients on Contemporary Heart Failure Treatment." JACC. Clinical Electrophysiology 10, no. 5 (2024): 916. https://doi.org/10.1016/j.jacep.2024.102334.

MLA (9th ed.) Citation

A, Ahmed, et al. "Mortality Benefit Among Primary Prevention Implantable Cardioverter-Defibrillator Recipients on Contemporary Heart Failure Treatment." JACC. Clinical Electrophysiology, vol. 10, no. 5, 2024, p. 916, https://doi.org/10.1016/j.jacep.2024.102334.